WO2024019673A1 - Antibacterial nanomaterial - Google Patents

Antibacterial nanomaterial Download PDF

Info

Publication number
WO2024019673A1
WO2024019673A1 PCT/TR2022/051152 TR2022051152W WO2024019673A1 WO 2024019673 A1 WO2024019673 A1 WO 2024019673A1 TR 2022051152 W TR2022051152 W TR 2022051152W WO 2024019673 A1 WO2024019673 A1 WO 2024019673A1
Authority
WO
WIPO (PCT)
Prior art keywords
antibacterial
nano
pvp
tube
immersion
Prior art date
Application number
PCT/TR2022/051152
Other languages
French (fr)
Inventor
Nurten ÖZEN
Tarik Baykara
Gamze TAYLAN
Ayça BAL ÖZTÜRK
Betül GIRAY
Original Assignee
Tc Demi̇roğlu Bi̇li̇m Üni̇versi̇tesi̇
Doğuş Üni̇versi̇tesi̇
İsti̇nye Üni̇versi̇tesi̇
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tc Demi̇roğlu Bi̇li̇m Üni̇versi̇tesi̇, Doğuş Üni̇versi̇tesi̇, İsti̇nye Üni̇versi̇tesi̇ filed Critical Tc Demi̇roğlu Bi̇li̇m Üni̇versi̇tesi̇
Publication of WO2024019673A1 publication Critical patent/WO2024019673A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08Materials for coatings
    • A61L29/085Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J15/00Feeding-tubes for therapeutic purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104Silver, e.g. silver sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/12Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces

Definitions

  • the invention relates to a chemical formulation coating to be applied to health apparatus and products such as injectors, especially nasogastric tubes (NGT) to be used in the medical field, in other words to areas where antibacterial/antifungal effect is desired.
  • injectors especially nasogastric tubes (NGT) to be used in the medical field, in other words to areas where antibacterial/antifungal effect is desired.
  • NTT nasogastric tubes
  • Enteral nutrition can be applied directly, with a tube, percutaneous interventions, or by surgical method to different parts of the system from the mouth to the jejunum.
  • Enteral nutrition is the continuous or intermittent administration of macro and micronutrients to the patient by nasogastric or nasoenteric, gastrostomy, or jejunostomy in patients with a functional gastrointestinal (GI) system.
  • GI gastrointestinal
  • NTT nasogastric tube
  • NET nasoenteric tube
  • gastrostomy or jejunostomy is opened for long-term nutrition.
  • Nasogastric tube is applied to hundreds of thousands of hospitalized patients every year for diagnostic, preventive, or therapeutic purposes as a complement to medical and surgical applications.
  • Nasogastric tube (NGT) application is the insertion of a plastic catheter into the stomach by inserting it through the nostril and esophagus.
  • Nasogastric tube application is an invasive application that is frequently used for enteral nutrition and concomitant drug administration, and stomach decompression and is under the responsibility of healthcare professionals. It is also used for irrigation and diagnostic applications of the stomach.
  • NGTs are made of materials such as polypropylene, polyvinylchloride, latex, silicone, or polyurethane. Tubes made of polyvinylchloride are generally suitable for short-term feeding that will last less than seven days. Polyurethane tubes are especially suitable for enteral nutrition. These tubes are made of polyurethane, which can remain soft and flexible, which is a nonreactive substance. When tubes are used for long periods, they may cause esophageal and gastric erosions in patients. The polyvinyl chloride tubes should be replaced every three to five days, and the silicone or polyurethane tubes after eight weeks.
  • Microorganisms such as methicillin-resistant Staphylococcus aureus (MRSA), which increase the mortality rate by 2-2.5 times, cause microbial colonization and contamination in NGT and these microorganisms use NGT as a reservoir.
  • MRSA methicillin-resistant Staphylococcus aureus
  • contamination of NGT with microorganisms leads to the development of many complications such as abdominal distension, bacteremia, diarrhea, pneumonia, and even death. Studies have shown that bacterial contamination develops 15 minutes after NGT placement; biofilm is formed in 60% of the tubes at the end of 24 hours and in all of them at the end of 48 hours, and the microorganisms that cause contamination on the outer surface of the NGT are also located inside the tube.
  • Nano-silver particles are known to be used to eliminate undesirable microorganisms and to prevent contamination due to their effective and wide-spectrum antibacterial activities. Even bacteria and viruses remain giant structures alongside nano-silver particles, and as soon as they come into contact with nanosized (0-200 nm) silver particles, their cellular structures deteriorate and die. Nano-silver has been attracting the attention of the scientific community for many years due to its antibacterial potency and the inability of bacteria to develop resistance to antibiotics against silver. Because of its nanoscale, when silver particles are coated on the surface of any material, the surface area increases several million times, providing a very strong antibacterial effect.
  • enteral nutrients are ideal environments for reproduction, and when contamination occurs, bacteria proliferate rapidly, and contamination of the gastrointestinal tract may lead to diarrhea.
  • wipe the formula box opening cover with an alcoholic cloth change the bedside formula set and bag routinely every 24 hours, to re-prepare the nutritional formulas every four hours, and to store the open formulas in the refrigerator.
  • the invention is described as “A nasogastric tube comprising at least one main lumen and at least one vacuum lumen comprising at least one suction port for sealing the inner wall of an esophagus against it, wherein the said at least one suction port includes a unique concave structure that significantly prevents tissue damage.”
  • Small complications of NGTs of the present application include nosebleeds, sinusitis, and sore throat.
  • the invention is a useful model, and discloses a nasogastric tube with a double tube cavity, including a perfusion tube cavity, wherein a guide wire tube cavity is provided in the tube body to guide the guide wire, the guide wire tube cavity end is a dead end, and the diameter of the pipe cavity of the guide wire is equivalent to that of the guide wire.
  • the advantages of the nasogastric tube are as follows: 1 it reduces the possibility of infection contamination by effectively solving the problem of direct contact of guide wire and exudates in vivo; 2 it greatly enhances the strength of the nasogastric tube body to properly place and position the tube into the body by adjusting the diameter of the nasogastric tube equivalent to that of the guide wire, thus finishes the process once with insertion, avoids repetitive procedures, and reduces patients' pain.
  • the present application is far from the solution we have presented.
  • the present invention relates to an antibacterial nanomaterial-coated nasogastric tube developed to eliminate the above-mentioned disadvantages and to bring new advantages to the related technical field.
  • the object of the invention is to provide an effective solution to show antibacterial/antifungal activity against pathogens on the surface of the NGT with the coating developed with the composition containing antibacterial/antifungal nano-silver ions.
  • Nano-silver used in the invention does not harm human health, pets, or plants, in other words, multicellular organisms. During its function, nano-silver does not react in any way, is not deformed and the continuity in its function continues. In this way, the antibacterial effect will be provided on the surfaces contacted by NGTs without harming the living organisms, and thus, negative effects that may occur due to the presence of various bacteria during patient treatment will be eliminated.
  • Another object of the invention is to expect the antibacterial cover to be applied on the nasogastric tube to show strong activity on different microorganisms such as both bacteria and fungi.
  • the fact that it is odorless, stain-free, non-toxic, and washable is one of the innovations that the product will bring.
  • “antibacterial coatings” will be obtained by using "Sol-Gel Coating” techniques, which is one of the most important applications of nano-coating technology.
  • NGTs will provide an antibacterial effect in the patient treatment process.
  • antibacterial effects will be provided on the surfaces contacted by the Nasogastric Tubes, thus, negative effects that may occur due to the presence of various bacteria during patient treatment will be eliminated.
  • the nano solution which has been tested for antibacterial activity in accordance with the standards, will be coated directly on the nasogastric tubes with spray, immersion, and brush application techniques and dried.
  • production can be carried out in series with a spraying method and subsequent effective drying phase in such a way that nasogastric tubes are homogeneously coated in a production line.
  • Sodium borohydride is used for antibacterial nanomaterial-coated NGTs. This compound is made of boron mineral and one of the most important purposes of its use in this invention is that it is a strong reducing agent. Sodium borohydride is used in the range of 30-45% by weight. In this way, it can store hydrogen in nanostructures at the appropriate pressure and temperature ranges and easily store them. Polyvinylpyrrolidone (PVP) is then added to this composition. The nanoparticles prepared by using this will have a homogeneous distribution in the solution. There will be equal concentrations of nano-silver particles everywhere. PVP is added in the range of 0.5-4.0% by weight. 0.5-2.0% oleic acid by weight is also added to the composition.
  • deionized water in the invention is that it is completely free of all organic, inorganic components and minerals within its framework.
  • deionized water since deionized water has no taste, smell, color, and conductivity, it does not affect the chemicals or solutions it comes into contact with.
  • the invention is a formulation applied to the antibacterial nanomaterial-coated nasogastric tube for use in the medical field; it comprises 30-45% Sodium Borohydride, 0.5-4% PVP, 0.5- 2% Oleic Acid, 30-35% Silver Nitrate, and 14-39% Deionized Water in the combination of the whole formula by weight.
  • the production method of the invention comprises the process steps; - Dissolving all chemicals separately in deionized water,
  • the maximum efficiency is 85 degrees and it can be preferred between 75-100 degrees.
  • the nonwoven fabric used is hydrophobic and repels the existing water.
  • the PVP and Sodium Borohydride used in the invention were used as reducing agents. While Silver Nitrate provides antibacterial properties, it acts as a stabilizer in oleic acid in the present invention.

Abstract

The invention relates to a chemical formulation coating to be applied to health apparatus and products such as injectors, especially nasogastric tubes (NGT) to be used in the medical field, in other words to areas where antibacterial/antifungal effect is desired.

Description

ANTIBACTERIAL NANOMATERIAL
TECHNICAL FIELD
The invention relates to a chemical formulation coating to be applied to health apparatus and products such as injectors, especially nasogastric tubes (NGT) to be used in the medical field, in other words to areas where antibacterial/antifungal effect is desired.
BACKGROUND
Enteral nutrition (EB) can be applied directly, with a tube, percutaneous interventions, or by surgical method to different parts of the system from the mouth to the jejunum. Enteral nutrition is the continuous or intermittent administration of macro and micronutrients to the patient by nasogastric or nasoenteric, gastrostomy, or jejunostomy in patients with a functional gastrointestinal (GI) system. While nasogastric tube (NGT) and nasoenteric tube (NET) are the most commonly used tools in short-term nutrition such as four to six weeks, gastrostomy or jejunostomy is opened for long-term nutrition.
Nasogastric tube (NGT) is applied to hundreds of thousands of hospitalized patients every year for diagnostic, preventive, or therapeutic purposes as a complement to medical and surgical applications. Nasogastric tube (NGT) application is the insertion of a plastic catheter into the stomach by inserting it through the nostril and esophagus. Nasogastric tube application is an invasive application that is frequently used for enteral nutrition and concomitant drug administration, and stomach decompression and is under the responsibility of healthcare professionals. It is also used for irrigation and diagnostic applications of the stomach.
Today, NGTs are made of materials such as polypropylene, polyvinylchloride, latex, silicone, or polyurethane. Tubes made of polyvinylchloride are generally suitable for short-term feeding that will last less than seven days. Polyurethane tubes are especially suitable for enteral nutrition. These tubes are made of polyurethane, which can remain soft and flexible, which is a nonreactive substance. When tubes are used for long periods, they may cause esophageal and gastric erosions in patients. The polyvinyl chloride tubes should be replaced every three to five days, and the silicone or polyurethane tubes after eight weeks.
Microorganisms such as methicillin-resistant Staphylococcus aureus (MRSA), which increase the mortality rate by 2-2.5 times, cause microbial colonization and contamination in NGT and these microorganisms use NGT as a reservoir. Contamination of NGT with microorganisms leads to the development of many complications such as abdominal distension, bacteremia, diarrhea, pneumonia, and even death. Studies have shown that bacterial contamination develops 15 minutes after NGT placement; biofilm is formed in 60% of the tubes at the end of 24 hours and in all of them at the end of 48 hours, and the microorganisms that cause contamination on the outer surface of the NGT are also located inside the tube.
Nano-silver particles are known to be used to eliminate undesirable microorganisms and to prevent contamination due to their effective and wide-spectrum antibacterial activities. Even bacteria and viruses remain giant structures alongside nano-silver particles, and as soon as they come into contact with nanosized (0-200 nm) silver particles, their cellular structures deteriorate and die. Nano-silver has been attracting the attention of the scientific community for many years due to its antibacterial potency and the inability of bacteria to develop resistance to antibiotics against silver. Because of its nanoscale, when silver particles are coated on the surface of any material, the surface area increases several million times, providing a very strong antibacterial effect.
As mentioned above, enteral nutrients are ideal environments for reproduction, and when contamination occurs, bacteria proliferate rapidly, and contamination of the gastrointestinal tract may lead to diarrhea. In order to prevent bacterial contamination in patients who are fed enterally, it is recommended to follow hand hygiene, wipe the formula box opening cover with an alcoholic cloth, change the bedside formula set and bag routinely every 24 hours, to re-prepare the nutritional formulas every four hours, and to store the open formulas in the refrigerator. However, all of these are insufficient in solving the problems in the art.
In document numbered “US10695269B2”, the invention is described as “A nasogastric tube comprising at least one main lumen and at least one vacuum lumen comprising at least one suction port for sealing the inner wall of an esophagus against it, wherein the said at least one suction port includes a unique concave structure that significantly prevents tissue damage.” Small complications of NGTs of the present application include nosebleeds, sinusitis, and sore throat. Sometimes, the emergence of more important complications such as abrasion, esophageal perforation, pulmonary aspiration, intracranial placement of a collapsed lung or tube in the nose where the tube is fixed has addressed the technical problem and it is claimed that there is a need for improved NGTs with suction ports that can pull the inner wall of an esophagus towards themselves without causing tissue damage due to the applied suction force. Therefore, it is far from our current technical problem and the solution we offer.
In the document numbered “CN201329127Y”, the invention is a useful model, and discloses a nasogastric tube with a double tube cavity, including a perfusion tube cavity, wherein a guide wire tube cavity is provided in the tube body to guide the guide wire, the guide wire tube cavity end is a dead end, and the diameter of the pipe cavity of the guide wire is equivalent to that of the guide wire. The advantages of the nasogastric tube are as follows: 1 it reduces the possibility of infection contamination by effectively solving the problem of direct contact of guide wire and exudates in vivo; 2 it greatly enhances the strength of the nasogastric tube body to properly place and position the tube into the body by adjusting the diameter of the nasogastric tube equivalent to that of the guide wire, thus finishes the process once with insertion, avoids repetitive procedures, and reduces patients' pain. However, the present application is far from the solution we have presented.
As a result, the need to eliminate the deficiencies and disadvantages of the embodiments and applications that exist in the current art and are used today makes it necessary to improve in the relevant technical field.
DESCRIPTION OF THE INVENTION
The present invention relates to an antibacterial nanomaterial-coated nasogastric tube developed to eliminate the above-mentioned disadvantages and to bring new advantages to the related technical field.
The object of the invention is to provide an effective solution to show antibacterial/antifungal activity against pathogens on the surface of the NGT with the coating developed with the composition containing antibacterial/antifungal nano-silver ions. Nano-silver used in the invention does not harm human health, pets, or plants, in other words, multicellular organisms. During its function, nano-silver does not react in any way, is not deformed and the continuity in its function continues. In this way, the antibacterial effect will be provided on the surfaces contacted by NGTs without harming the living organisms, and thus, negative effects that may occur due to the presence of various bacteria during patient treatment will be eliminated.
Another object of the invention is to expect the antibacterial cover to be applied on the nasogastric tube to show strong activity on different microorganisms such as both bacteria and fungi. At the same time, the fact that it is odorless, stain-free, non-toxic, and washable is one of the innovations that the product will bring. With this study, "antibacterial coatings" will be obtained by using "Sol-Gel Coating" techniques, which is one of the most important applications of nano-coating technology.
Thanks to this invention, currently used NGTs will provide an antibacterial effect in the patient treatment process. In this way, antibacterial effects will be provided on the surfaces contacted by the Nasogastric Tubes, thus, negative effects that may occur due to the presence of various bacteria during patient treatment will be eliminated.
DETAILED DESCRIPTION OF THE INVENTION
In this detailed description, the preferred alternatives of the embodiment of the present invention are merely explained for a better understanding of the subject of the present invention, which is not intended to be limiting in any way.
The nano solution, which has been tested for antibacterial activity in accordance with the standards, will be coated directly on the nasogastric tubes with spray, immersion, and brush application techniques and dried. For industrial applications, production can be carried out in series with a spraying method and subsequent effective drying phase in such a way that nasogastric tubes are homogeneously coated in a production line.
Sodium borohydride is used for antibacterial nanomaterial-coated NGTs. This compound is made of boron mineral and one of the most important purposes of its use in this invention is that it is a strong reducing agent. Sodium borohydride is used in the range of 30-45% by weight. In this way, it can store hydrogen in nanostructures at the appropriate pressure and temperature ranges and easily store them. Polyvinylpyrrolidone (PVP) is then added to this composition. The nanoparticles prepared by using this will have a homogeneous distribution in the solution. There will be equal concentrations of nano-silver particles everywhere. PVP is added in the range of 0.5-4.0% by weight. 0.5-2.0% oleic acid by weight is also added to the composition. With this addition, moisture is provided on the surface in the nano-silver solution. In addition, for antibacterial activity as the most important main compound, silver nitrate, which will be reduced to the nano-size, is added between 30-35% by weight and the nano solution is prepared. The nanosized solution, which is mixed with a mechanical stirrer for 24 hours in an extremely homogeneous manner, is applied on NGTs by spraying, immersion, and brush application methods and allowed to dry. (Parts 1 and 2).
The reason for using deionized water in the invention is that it is completely free of all organic, inorganic components and minerals within its framework. In addition, since deionized water has no taste, smell, color, and conductivity, it does not affect the chemicals or solutions it comes into contact with.
Figure imgf000006_0001
The invention is a formulation applied to the antibacterial nanomaterial-coated nasogastric tube for use in the medical field; it comprises 30-45% Sodium Borohydride, 0.5-4% PVP, 0.5- 2% Oleic Acid, 30-35% Silver Nitrate, and 14-39% Deionized Water in the combination of the whole formula by weight.
The production method of the invention comprises the process steps; - Dissolving all chemicals separately in deionized water,
- Adding PVP (Polyvinylpyrrolidone) to Sodium Borohydride,
- Adding oleic acid to the resulting chemical mixture,
- Adding silver nitrate to the resulting mixture,
- Mixing the resulting mixture homogeneously preferably with a mechanical stirrer for 24 hours,
- Applying the nano-sized solution on the apparatus to be directly applied by spraying or immersion or brush application methods or preferably on a hydrophobic nonwoven fabric by immersion, spraying or brush application methods,
- Allowing the applied process to dry preferably at 75-100 degrees in the oven.
From the temperature values used in the invention, the maximum efficiency is 85 degrees and it can be preferred between 75-100 degrees.
The nonwoven fabric used is hydrophobic and repels the existing water.
The PVP and Sodium Borohydride used in the invention were used as reducing agents. While Silver Nitrate provides antibacterial properties, it acts as a stabilizer in oleic acid in the present invention.

Claims

CLAIMS Antibacterial nanomaterials for use in the medical field, characterized in that it comprises 30-45% Sodium Borohydride, 0.5-4% PVP, 0.5-2% Oleic Acid, 30-35% Silver Nitrate, and 14-39% Deionized Water by weight in the combination of the whole formula. A method for producing the antibacterial nanomaterial for use in the medical field, characterized in that it comprises the process steps;
- Dissolving all chemicals separately in deionized water,
- Adding PVP (Polyvinylpyrrolidone) to Sodium Borohydride,
- Adding oleic acid to the resulting chemical mixture,
- Adding silver nitrate to the resulting mixture,
- Mixing the resulting mixture homogeneously preferably with a mechanical stirrer for 24 hours,
- Applying the nano-sized solution on the apparatus to be directly applied by spraying or immersion or brush application methods or preferably on a hydrophobic nonwoven fabric by immersion, spraying or brush application methods,
- Allowing the applied process to dry preferably at 75-100 degrees in the oven.
PCT/TR2022/051152 2022-07-21 2022-10-18 Antibacterial nanomaterial WO2024019673A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2022/011677 2022-07-21
TR2022/011677A TR2022011677A2 (en) 2022-07-21 2022-07-21 ANTIBACTERIAL NANO MATERIAL

Publications (1)

Publication Number Publication Date
WO2024019673A1 true WO2024019673A1 (en) 2024-01-25

Family

ID=84101129

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2022/051152 WO2024019673A1 (en) 2022-07-21 2022-10-18 Antibacterial nanomaterial

Country Status (2)

Country Link
TR (1) TR2022011677A2 (en)
WO (1) WO2024019673A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1266761A (en) * 2000-03-23 2000-09-20 南京大学 Process for preparing nm-class silver powder
CN101731272A (en) * 2009-12-24 2010-06-16 中国人民解放军军事医学科学院基础医学研究所 Method for preparing antibacterial nanometer silver colloid
CN114734049A (en) * 2022-03-14 2022-07-12 上海大学 Method for preparing ultra-small nano silver by using sodium borohydride

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1266761A (en) * 2000-03-23 2000-09-20 南京大学 Process for preparing nm-class silver powder
CN101731272A (en) * 2009-12-24 2010-06-16 中国人民解放军军事医学科学院基础医学研究所 Method for preparing antibacterial nanometer silver colloid
CN114734049A (en) * 2022-03-14 2022-07-12 上海大学 Method for preparing ultra-small nano silver by using sodium borohydride

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ALMATROUDI, A.: "Silver nanoparticles: synthesis, characterisation and biomedical applications", OPEN LIFE SCIENCES, vol. 15, no. 1, 19 November 2020 (2020-11-19), pages 819 - 839, XP093132917 *

Also Published As

Publication number Publication date
TR2022011677A2 (en) 2022-08-22

Similar Documents

Publication Publication Date Title
CN101579550B (en) Artificial trachea cannula made of nano materials and preparation method thereof
US7147625B2 (en) Leg bag accessory
US20100068296A1 (en) Methods for producing an anti-microbial plastic product
CN109364100A (en) A kind of nanometer vulcanization iron mixture of high-efficiency antimicrobial and its preparation method and application
Barnes et al. Antimicrobial polymer modifications to reduce microbial bioburden on endotracheal tubes and ventilator associated pneumonia
JP2007534361A (en) Device and method for administering therapeutic agents
Zholobak et al. Interaction of nanoceria with microorganisms
AU2007331740B2 (en) Tube for enteral nutrition
CN101653635A (en) Manual tracheotomy tube with antibacterial nano material coating
CN102389743A (en) Formula of medical bacteriostatic humidifying solution
CN101554505A (en) Artificial trachea cannula with nanometre anti-microbial coating
CN104740690A (en) Medicine-carrying nano antibacterial super-smooth coating for marine organisms
WO2024019673A1 (en) Antibacterial nanomaterial
Lethongkam et al. Biogenic nanosilver-fabricated endotracheal tube to prevent microbial colonization in a veterinary hospital
CN1245152C (en) Nano-silver aqueous solution preparation and its preparation method, use and using method
CN102614294B (en) Compound amoxicillin suspension injection and preparation method thereof
CN111529682A (en) Chemotaxis antibacterial nano material and preparation method and application thereof
Karademir et al. Antimicrobial Surface Functionality of PEG Coated and AgNPs Immobilized Extracorporeal Biomaterials
CN108329496A (en) A kind of medical grade rubber material and preparation method thereof of chitosan oligosaccharide nano silver/graphene oxide modification
WO2014138885A1 (en) Polymeric coatings having antimicrobial properties
KR20060092776A (en) Nano silver contend catheter
CN201404565Y (en) Artificial trachea cannula with nano antibiotic material coating
CN112294789A (en) Compound preparation for preventing and treating respiratory tract infection and application thereof
CN201481948U (en) Artificial trachea cutting sleeve of anti-bacterial nano material coating layer
US20230413814A1 (en) A method for removing a biofilm

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22952107

Country of ref document: EP

Kind code of ref document: A1